Cross Country Healthcare - CCRN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $23.14
  • Forecasted Upside: 36.13%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$17.00
▲ +0.01 (0.06%)

This chart shows the closing price for CCRN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cross Country Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCRN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCRN

Analyst Price Target is $23.14
▲ +36.13% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Cross Country Healthcare in the last 3 months. The average price target is $23.14, with a high forecast of $30.00 and a low forecast of $16.00. The average price target represents a 36.13% upside from the last price of $17.00.

This chart shows the closing price for CCRN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 polled investment analysts is to hold stock in Cross Country Healthcare. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2024Truist FinancialLower TargetHold ➝ Hold$22.00 ➝ $16.00Low
2/22/2024BenchmarkLower TargetBuy ➝ Buy$24.00 ➝ $21.00Low
12/6/2023JMP SecuritiesInitiated CoverageMarket PerformLow
11/30/2023UBS GroupInitiated CoverageNeutral$22.00Low
11/29/2023Barrington ResearchLower TargetOutperform ➝ Outperform$29.00 ➝ $26.00Low
11/3/2023Truist FinancialLower TargetHold ➝ Hold$25.00 ➝ $22.00Low
11/3/2023Jefferies Financial GroupReiterated RatingBuy ➝ Hold$32.00 ➝ $21.00N/A
10/5/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$40.00 ➝ $32.00Low
8/14/2023Barrington ResearchLower TargetOutperform ➝ Outperform$35.00 ➝ $29.00Low
8/8/2023Credit Suisse GroupLower TargetNeutral ➝ Neutral$27.00 ➝ $26.00Low
6/26/2023William BlairInitiated CoverageOutperformLow
5/31/2023Barrington ResearchLower Target$42.00 ➝ $35.00Low
5/2/2023Truist FinancialLower Target$38.00 ➝ $25.00Low
3/9/2023Loop CapitalInitiated CoverageBuy$30.00Low
2/23/2023BenchmarkLower TargetBuy$45.00 ➝ $40.00Low
2/23/2023Credit Suisse GroupBoost TargetNeutral$31.00 ➝ $32.00Low
11/24/2022Credit Suisse GroupBoost Target$31.00Low
11/7/2022Barrington ResearchBoost TargetOutperform$41.00 ➝ $45.00Low
10/5/2022Truist FinancialDowngradeBuy ➝ Hold$36.00Low
9/15/2022BenchmarkBoost TargetBuy$37.00 ➝ $42.00Low
8/22/2022Barrington ResearchLower Target$40.00Low
6/13/2022BenchmarkLower TargetBuy$42.00 ➝ $37.00High
6/9/2022Credit Suisse GroupLower TargetNeutral$28.00 ➝ $26.00High
4/11/2022Barrington ResearchBoost Target$33.00 ➝ $44.00Low
2/24/2022BenchmarkBoost TargetBuy$33.00 ➝ $42.00High
1/27/2022Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $27.00High
11/18/2021Barrington ResearchBoost TargetOutperform$22.00 ➝ $33.00Medium
8/31/2021Truist FinancialBoost TargetBuy$19.00 ➝ $23.00Medium
8/18/2021Barrington ResearchReiterated RatingBuy$17.00High
8/16/2021Credit Suisse GroupBoost TargetNeutral$13.50 ➝ $19.00High
8/5/2021BenchmarkUpgradeHold ➝ Buy$22.00High
6/14/2021BMO Capital MarketsBoost TargetOutperform$17.00 ➝ $20.00Low
5/21/2021Barrington ResearchBoost TargetOutperform$14.00 ➝ $17.00Low
5/12/2021BenchmarkReiterated RatingBuy ➝ HoldHigh
5/6/2021Credit Suisse GroupBoost TargetNeutral$11.00 ➝ $13.50Medium
5/6/2021BenchmarkDowngradeBuy ➝ HoldHigh
2/25/2021Credit Suisse GroupBoost TargetNeutral$10.00 ➝ $11.00High
2/22/2021Barrington ResearchReiterated RatingBuy$12.00Medium
11/23/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$10.00Medium
11/5/2020Credit Suisse GroupBoost TargetNeutral$7.00 ➝ $8.50High
11/5/2020BMO Capital MarketsBoost TargetMarket Perform$7.00 ➝ $9.00Medium
11/5/2020BenchmarkUpgradeHold ➝ Buy$11.00High
10/30/2020Truist FinancialUpgradeHold ➝ Buy$7.00 ➝ $10.00High
10/8/2020Bank of AmericaInitiated CoverageUnderperform$7.50High
8/17/2020OppenheimerReiterated RatingHold ➝ NeutralMedium
8/12/2020Barrington ResearchReiterated RatingBuy$9.00Medium
8/6/2020Credit Suisse GroupBoost TargetNeutral$6.50 ➝ $7.00High
5/18/2020Barrington ResearchLower TargetOutperform$11.00 ➝ $9.00Medium
5/15/2020OppenheimerReiterated RatingHoldLow
5/8/2020SunTrust BanksLower TargetHold$9.00 ➝ $7.00Low
3/26/2020SunTrust BanksLower TargetHold$12.00 ➝ $9.00High
3/10/2020Barrington ResearchReiterated RatingOutperformHigh
5/20/2019Barrington ResearchSet TargetBuy$10.00Medium
2/28/2019BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$10.00 ➝ $8.00Medium
(Data available from 2/24/2019 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/29/2023
  • 13 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/28/2023
  • 10 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2023
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2023
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2024
  • 16 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/24/2024

Current Sentiment

  • 16 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Cross Country Healthcare logo
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; managed services programs services; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $17.00
Low: $16.36
High: $17.18

50 Day Range

MA: $21.35
Low: $16.99
High: $23.52

52 Week Range

Now: $17.00
Low: $15.65
High: $28.75

Volume

602,408 shs

Average Volume

769,147 shs

Market Capitalization

$597.55 million

P/E Ratio

8.37

Dividend Yield

N/A

Beta

0.77

Frequently Asked Questions

What sell-side analysts currently cover shares of Cross Country Healthcare?

The following equities research analysts have issued stock ratings on Cross Country Healthcare in the last year: Barrington Research, Benchmark Co., Credit Suisse Group AG, Jefferies Financial Group Inc., JMP Securities, Loop Capital, StockNews.com, Truist Financial Co., UBS Group AG, and William Blair.
View the latest analyst ratings for CCRN.

What is the current price target for Cross Country Healthcare?

7 Wall Street analysts have set twelve-month price targets for Cross Country Healthcare in the last year. Their average twelve-month price target is $23.14, suggesting a possible upside of 36.1%. Loop Capital has the highest price target set, predicting CCRN will reach $30.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $16.00 for Cross Country Healthcare in the next year.
View the latest price targets for CCRN.

What is the current consensus analyst rating for Cross Country Healthcare?

Cross Country Healthcare currently has 5 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CCRN, but not buy more shares or sell existing shares.
View the latest ratings for CCRN.

What other companies compete with Cross Country Healthcare?

Other companies that are similar to Cross Country Healthcare include Barrett Business Services, Kelly Services, TrueBlue, TTEC and DLH. Learn More about companies similar to Cross Country Healthcare.

How do I contact Cross Country Healthcare's investor relations team?

Cross Country Healthcare's physical mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider's listed phone number is (561) 998-2232 and its investor relations email address is [email protected]. The official website for Cross Country Healthcare is www.crosscountryhealthcare.com. Learn More about contacing Cross Country Healthcare investor relations.